Improving seroreactivity-based detection of glioma

Neoplasia

Volumn 11, Issue 12, 2009, Pages 1383-1389

  Ludwig, Nicole ^a   Keller, Andreas ^b   Heisel, Sabrina ^a   Leidinger, Petra ^a   Klein, Veronika ^a   Rheinheimer, Stefanie ^a   Andres, Claudia U ^b   Stephan, Bernhard ^a   Steudel, Wolf Ingo ^a   Graf, Norbert M ^a   Burgeth, Bernhard ^b   Weickert, Joachim ^b   Lenhof, Hans Peter ^b   Meese, Eckart ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; VIMENTIN;

ACCURACY; ADULT; AGED; AMINO ACID SEQUENCE; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CLONE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GENE; GLIOMA; HUMAN; IMMUNOGENICITY; IMMUNOTHERAPY; INFORMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SERUM; SUPPORT VECTOR MACHINE; TUMOR CLASSIFICATION; WORLD HEALTH ORGANIZATION;

EID: 72949091249     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.91018     Document Type: Article

References (42)

1. CBTRUS (2008). Statistical Report: Primary Brain Tumors in the United States, 2000-2004. Central Brain Tumor Registry of the United States.
2. Kleihues P and Cavenee WK (2000). Pathology and Genetics of Tumours of the Nervous System. Pathology and Genetics of Tumours of the Nervous System Lyon, France: IARC Press, 9-52.
3. Pillay V, Allaf L, Wilding AL, Donoghue JF, Court NW, Greenall SA, Scott AM, and Johns TG (2009). The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases. Neoplasia 11, 448-458.
4. Selznick LA, Shamji MF, Fecci P, Gromeier M, Friedman AH, and Sampson J (2008). Molecular strategies for the treatment of malignant glioma - genes, viruses, and vaccines. Neurosurg Rev 31, 141-155.
5. Wang X, Yu J, Sreekumar A, Varambally S, Shen R, Giacherio D, Mehra R, Montie JE, Pienta KJ, Sanda MG, et al. (2005). Autoantibody signatures in prostate cancer. N Engl J Med 353, 1224-1235.
6. Zhong L, Hidalgo GE, Stromberg AJ, Khattar NH, Jett JR, and Hirschowitz EA (2005). Using protein microarray as a diagnostic assay for non-small cell lung cancer. Am J Respir Crit Care Med 172, 1308-1314.
7. Chen G, Wang X, Yu J, Varambally S, Yu J, Thomas DG, Lin MY, Vishnu P, Wang Z, Wang R, et al. (2007). Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma. Cancer Res 67, 3461-3467.
8. Chatterjee M, Mohapatra S, Ionan A, Bawa G, Ali-Fehmi R, Wang X, Nowak J, Ye B, Nahhas FA, Lu K, et al. (2006). Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res 66, 1181-1190.
9. Erkanli A, Taylor DD, Dean D, Eksir F, Egger D, Geyer J, Nelson BH, Stone B, Fritsche HA, and Roden RB (2006). Application of Bayesian modeling of autologous antibody responses against ovarian tumor-associated antigens to cancer detection. Cancer Res 66, 1792-1798.
10. Comtesse N, Zippel A, Walle S, Monz D, Backes C, Fischer U, Mayer J, Ludwig N, Hildebrandt A, Keller A, et al. (2005). Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets. Proc Natl Acad Sci USA 102, 9601-9606.
11. Keller A, Ludwig N, Comtesse N, Hildebrandt A, Meese E, and Lenhof HP (2006). A minimally invasive multiple marker approach allows highly efficient detection of meningioma tumors. BMC Bioinformatics 7, 539.
12. Ludwig N, Keller A, Comtesse N, Rheinheimer S, Pallasch C, Fischer U, Fassbender K, Steudel WI, Lenhof HP, and Meese E (2008). Pattern of serum autoantibodies allows accurate distinction between a tumor and pathologies of the same organ. Clin Cancer Res 14, 4767-4774.
13. Leidinger P, Keller A, Ludwig N, Rheinheimer S, Hamacher J, Huwer H, Stehle I, Lenhof HP, and Meese E (2008). Toward an early diagnosis of lung cancer: an autoantibody signature for squamous cell lung carcinoma. Int J Cancer 123, 1631-1636.
14. Fernández-Madrid F, Tang N, Alansari H, Granda JL, Tait L, Amirikia KC, Moroianu M, Wang X, and Karvonen RL (2004). Autoantibodies to annexin XI-A and other autoantigens in the diagnosis of breast cancer. Cancer Res 64, 5089-5096.
15. Zhong L, Ge K, Zu JC, Zhao LH, Shen WK, Wang JF, Zhang XG, Gao X, Hu W, Yen Y, et al. (2008). Autoantibodies as potential biomarkers for breast cancer. Breast Cancer Res 10, R40.
16. Ran Y, Hu H, Zhou Z, Yu L, Sun L, Pan J, Liu J, and Yang Z (2008). Profiling tumor-associated autoantibodies for the detection of colon cancer. Clin Cancer Res 14, 2696-2700.
17. Lin HS, Talwar HS, Tarca AL, Ionan A, Chatterjee M, Ye B, Wojciechowski J, Mohapatra S, Basson MD, Yoo GH, et al. (2007). Autoantibody approach for serum-based detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev 16, 2396-2405.
18. Zhong L, Coe SP, Stromberg AJ, Khattar NH, Jett JR, and Hirschowitz EA (2006). Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol 1, 513-519.
19. Chapman CJ, Murray A, McElveen JE, Sahin U, Luxemburger U, Türeci O, Wiewrodt R, Barnes AC, and Robertson JF (2008). Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax 63, 228-233.
20. Büssow K, Cahill D, NietfeldW, Bancroft D, Scherzinger E, Lehrach H, andWalter G (1998). A method for global protein expression and antibody screening on highdensity filters of an arrayed cDNA library. Nucleic Acids Res 26, 5007-5008.
21. Coakham HB, Kornblith PL, Quindlen EA, Pollock LA, Wood WC, and Hartnett LC (1980). Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays. J Natl Cancer Inst 64, 223-233.
22. Apuzzo ML (1976). Tumor immunology: a neurosurgical perspective. II. The immunology of glial neoplasms. Bull Los Angeles Neurol Soc 41, 176-183.
23. Wood WC, Kornblith PL, Quindlen EA, and Pollock LA (1979). Detection of humoral immune response to human brain tumors: specificity and reliability of microcytotoxicity assay. Cancer 43, 86-90.
24. Sahin U, Tureci O, and Schmitt H (1995). Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92, 11810-11813.
25. Bonnycastle LLC, Mehroke JS, Rashed M, Gong X, and Scott JK (1996). Probing the basis of antibody reactivity with a panel of constrained peptide libraries displayed by filamentous phage. J Mol Biol 258, 747-762.
26. Cancer Immunome Database. Available at: http://ludwig-sun5.unil.ch/ Cancer-ImmunomeDB/.
27. Fischer U, Struss AK, Hemmer D, Pallasch CP, Steudel WI, and Meese E (2001). Glioma-expressed antigen 2 (GLEA2): a novel protein that can elicit immune responses in glioblastoma patients and some controls. Clin Exp Immunol 126, 206-213.
28. Struss AK, Romeike BF, Munnia A, Nastainczyk W, Steudel WI, König J, Ohgaki H, Feiden W, Fischer U, and Meese E (2001). PHF3-specific antibody responses in over 60% of patients with glioblastoma multiforme. Oncogene 12, 4107-4114.
29. Schmits R, Cochlovius B, Treitz G, Regitz E, Ketter R, Preuss KD, Romeike BF, and Pfreundschuh M (2002). Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas. Int J Cancer 98, 73-77.
30. Colin C, Virard I, Baeza N, Tchoghandjian A, Fernandez C, Bouvier C, Calisti A, Tong S, Durbec P, and Figarella-Branger D (2007). Relevance of combinatorial profiles of intermediate filaments and transcription factors for glioma histogenesis. Neuropathol Appl Neurobiol 33, 431-439.
31. Peria FM, Neder L, Marie SK, Rosemberg S, Oba-Shinjo SM, Colli BO, Gabbai AA, Malheiros SM, Zago MA, Panepucci RA, et al. (2007). Pleiotrophin expression in astrocytic and oligodendroglial tumors and it's correlation with histological diagnosis, microvascular density, cellular proliferation and overall survival. J Neurooncol 84, 255-261.
32. Rutka JT, Ivanchuk S, Mondal S, Taylor M, Sakai K, Dirks P, Jun P, Jung S, Becker LE, and Ackerley C (1999). Co-expression of nestin and vimentin intermediate filaments in invasive human astrocytoma cells. Int J Dev Neurosci 17, 503-515.
33. Moisan E and Girard D (2006). Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis. J Leukoc Biol 79, 489-498.
34. Gensler TJ, Hottelet M, Zhang C, Schlossman S, Anderson P, and Utz PJ (2001). Monoclonal antibodies derived from BALB/c mice immunized with apoptotic Jurkat T cells recognize known autoantigens. J Autoimmun 16, 59-69.
35. Hong SH, Misek DE, Wang H, Puravs E, Hinderer R, Giordano TJ, Greenson JK, Brenner DE, Simeone DM, Logsdon CD, et al. (2006). Identification of a specific vimentin isoform that induces an antibody response in pancreatic cancer. Biomark Insights 1, 175-183.
36. Engelmann R, Brandt J, Eggert M, Karberg K, Krause A, Neeck G, and Mueller-Hilke B (2008). IgG1 and IgG4 are the predominant subclasses among autoantibodies against two citrullinated antigens in RA. Rheumatology (Oxford) 47, 1489-1492.
37. Liau LM, Prins RM, Kiertscher SM, Odesa SK, Kremen TJ, Giovannone AJ, Lin JW, Chute DJ, Mischel PS, Cloughesy TF, et al. (2005). Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment. Clin Cancer Res 11, 5515-5525.
38. Sampson JH, Archer GE, Mitchell DA, Heimberger AB, and Bigner DD (2008). Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma. Semin Immunol 20, 267-275.
39. Yamanaka R, Homma J, Yajima N, Tsuchiya N, Sano M, Kobayashi T, Yoshida S, Abe T, Narita M, Takahashi M, et al. (2005). Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial. Clin Cancer Res 11, 4160-4167.
40. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, et al. (2009). Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360, 1320-1328.
41. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S, Johnson D, et al. (2008). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134, 1570-1595.
42. Trivers GE, De Benedetti VM, Cawley HL, Caron G, Harrington AM, Bennett WP, Jett JR, Colby TV, Tazelaar H, Pairolero P, et al. (1996). Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer. Clin Cancer Res 2, 1767-1775.